A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
Determinants of an Optimal Response to Pioglitazone in Terms of HDL-Cholesterol
Internal medicine (Tokyo. 1992)
Objective The effect of pioglitazone on high-density lipoprotein cholesterol (HDL-C) has been attracting attention. However, there are limited data on the characteristics of patients who are likely to respond to pioglitazone in terms of the improvement in HDL-C levels (lipid responders). In the present study, the characteristics of lipid responders were investigated. Methods Five hundred and sixty-three patients with type 2 diabetes who started pioglitazone treatment were followed for sixdoi:10.2169/internalmedicine.50.4853 pmid:21498929 fatcat:jw7yhiabjzdgpiynb3sf3evd3u